The physicians and organizations who have made this recommendation include Vermont’s Cannabis Control Board, physicians from the Vermont Medical Society, the American Academy of Pediatrics Vermont Chapter, the Vermont Psychiatric Association and the Vermont Academy of Family Physicians.
State lawmakers previously voted on a similar bill to maintain the state’s 60 percent THC cap on solid concentrate products and a 30 percent cap on cannabis flower.
“Our organizations believe it is premature to reopen this debate when Vermont’s cannabis sales just came online, initial revenue estimates appear to be meeting their targets, and states like [Colorado] and [Washington] are currently seeking stronger regulation of solid concentrates because of the negative health impacts on their users,” the organizations said in a joint statement with Vermont Business Magazine.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.